Anesthesia and analgesia
-
Anesthesia and analgesia · Oct 1992
Randomized Controlled Trial Clinical TrialVomiting after alfentanil anesthesia: effect of dosing method.
This double-blind study correlated the association of nausea and vomiting after alfentanil with its method of administration (bolus dose vs continuous infusion). Of 40 women undergoing lower abdominal gynecologic or laparoscopic surgery, 20 received an intravenous alfentanil (30 micrograms/kg) bolus dose for induction of anesthesia, with subsequent bolus doses of 10 micrograms/kg every 10 min, and 20 received the same induction dose delivered over 1 min, followed by an intravenous infusion at 1.0 micrograms.kg-1.min-1. ⋯ Laparoscopy and alfentanil infusion combined synergistically to worsen the incidence of nausea and vomiting. We conclude that alfentanil infusion for laparoscopic surgery entails a high risk for nausea and vomiting.
-
Anesthesia and analgesia · Oct 1992
Randomized Controlled Trial Comparative Study Clinical TrialOndansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide.
The prophylactic antiemetic efficacy of ondansetron was evaluated in a randomized, double-blind comparison with droperidol and metoclopramide in 66 patients undergoing general anesthesia for dilatation and curettage. Ten minutes before induction of anesthesia, 22 patients received a single intravenous dose of 8 mg of ondansetron, 22 others received 1.25 mg of droperidol, and the remaining 22 received 10 mg of metoclopramide. Anesthesia was induced with 3.3-5 mg/kg of intravenous thiopental and maintained with 65% nitrous oxide in oxygen and 2%-3% enflurane. ⋯ There was no statistically significant difference in the incidence of nausea among the groups. Postoperative sedation and well-being scores were not significantly different among the groups. We conclude that preoperative prophylactic administration of ondansetron is superior to droperidol or metoclopramide in the prevention of emetic sequelae after general anesthesia for dilatation and curettage.
-
Anesthesia and analgesia · Oct 1992
ReviewAn overview of induction and emergence characteristics of desflurane in pediatric, adult, and geriatric patients.
A major advantage of desflurane over currently available agents is that the blood-gas partition coefficient of desflurane is 0.42, lower than all available volatile anesthetics, and slightly lower than nitrous oxide. This property predicts rapid induction of and recovery from general anesthesia with desflurane. This review will summarize and compare results of studies that have examined various clinical characteristics of induction and emergence with desflurane in a variety of patient populations. ⋯ Several studies have compared emergence from anesthesia with desflurane with that from isoflurane-based anesthetics, and have demonstrated that initial emergence from a given depth of anesthesia, e.g., time to eye opening or response to verbal commands, is about twice as fast with desflurane. Similar results have been obtained in pediatric patients where emergence from desflurane is faster than that seen from halothane. Emergence from desflurane anesthesia appears similar in time-course to that from propofol-based anesthetics.(ABSTRACT TRUNCATED AT 250 WORDS)
-
This prospective study was performed to determine whether anesthesia clinicians (i.e., both anesthesiologists and nurse anesthetists) can identify operating room alarms by their distinctive sounds and to identify factors related to alarm recognition accuracy. Nineteen alarms from 15 commonly used devices were recorded. These sounds were played, in a quiet room, to 44 anesthesia clinicians. ⋯ Complexity of the sound did not influence accuracy of recognition. Most errors were attributed to similarities in sound or function, or both, among alarms. We conclude that anesthetists cannot reliably identify current operating room alarms by their distinctive sounds.
-
Anesthesia and analgesia · Oct 1992
ReviewDesflurane animal and human pharmacology: aspects of kinetics, safety, and MAC.
Substitution of fluorine for the single chlorine atom in isoflurane produces the new anesthetic, desflurane. This seemingly small change produces several pharmacologic changes. The potency of desflurane (MAC equals 6.0% in middle-aged patients) is one-fifth that of isoflurane (1.15%), with MAC for each agent decreased by aging, hypothermia, or the addition of depressants such as midazolam, fentanyl, or nitrous oxide. ⋯ Of great importance, the substitution of fluorine for chlorine markedly decreases blood (desflurane blood-gas partition coefficient 0.42) and tissue solubility (e.g., brain-blood partition coefficient 1.3) relative to isoflurane (values 1.4 and 1.6, respectively). As a result, desflurane alveolar concentrations may be adjusted more rapidly and precisely; desflurane enters and leaves the lungs and tissues more rapidly; and recovery is quicker both for the short (first 10-20 min) and long (0.5-1.5 h) term. This greater precision of control and more rapid recovery are consistent with trends for new drug development in anesthesiology.